Timolol Impurity 1 | CAS 75014-25-4 - Request Quote
Timolol Impurity 1
| SZ CAT No: | SZ-T018015 |
| CAS No | 75014-25-4 |
| Mol.F. | C13H24N4O5S |
| Mol.Wt. | 348.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Timolol Impurity 1 is chemically (S)-N-(4-(3-(tert-butylamino)-2-hydroxypropoxy)-1,2,5-thiadiazol-3-yl)-N-(2-hydroxyethyl)glycine. Timolol Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Timolol Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Timolol.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 75014-25-4
Purchase 75014-25-4
Order 75014-25-4
Enquire 75014-25-4
price of 75014-25-4
75014-25-4 Supplier
75014-25-4 Manufacturer
75014-25-4 Exporter
buy high quality Timolol Impurity 1
Purchase Timolol Impurity 1
Timolol Impurity 1 suppliers
Timolol Impurity 1 manufacturers
Timolol Impurity 1 price
Order Timolol Impurity 1
Enquire Timolol Impurity 1
Timolol Impurity 1 cost
Timolol Impurity 1 Supplier
Timolol Impurity 1 Distributor
Timolol Impurity 1 for Method Validation
Timolol Reference Standard
Timolol Impurity 1 for ANDA Filing
Timolol Impurity 1 for Forced Degradation Studies
Timolol Impurity 1 Identification Standards
Timolol Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


